Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 934 participants.
Also called NCT07526987
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 934 participants
- Sponsor
- Registry
-
NCT07526987
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07526987. Randomized; quadruple masking; primary purpose treatment. Start 2026-06-05 (actual); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis
- Acronym
- EMPHASIS-2
- Condition
- Ischaemic Stroke
- Intervention (Drug)
- Minocycline Hydrochloride Capsule (50 mg per capsule)
- Intervention (Drug)
- Placebo of Minocycline Hydrochloride Capsule (50 mg per capsule, containing 0 mg of minocycline)
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct07526987- Content hash
e9e2aa49c2006d4a99430b228f76cff23c2e28d2ec644728022257062788c13f